Market Report / Israeli stocks set two-and-a-half-year high
Teva buoyed by success of late-stage clinical trial to treat multiple sclerosis.
this story is by
The Tel Aviv Stock Exchange closed at a two-and-a-half-year high Sunday, making up losses incurred Thursday when index compositions were rebalanced. Shares were pulled up by optimism and arbitrage gaps that opened over the weekend.